At the recent Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, I spoke about what really matters when measuring diversity in clinical trials.
EGFR inhibitor drugs have proven to be effective in treating several types of cancers, but they can come with uncomfortable side effects. Here’s what...
Encouraging and Facilitating Diverse Participation in Clinical Trials | An Empowered Patient Podcast by Karen Jagoda Dr. Eddilisa Martin is the CEO and Founder of...
